openPR Logo
Press release

Epileptic Seizures Treatment Market Expected to Reach US$ 1.8 Billion by 2030, Growing at a CAGR of 4%: TMR Study

02-20-2024 09:06 AM CET | Health & Medicine

Press release from: Transparency Market Research

Epileptic Seizures Treatment

Epileptic Seizures Treatment

๐„๐ฉ๐ข๐ฅ๐ž๐ฉ๐ญ๐ข๐œ ๐ฌ๐ž๐ข๐ณ๐ฎ๐ซ๐ž๐ฌ ๐ญ๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐ฆ๐š๐ซ๐ค๐ž๐ญ to reach Valuation Of US$ 1.8 Bn By 2030, projected to expand at a CAGR of ~4% from 2020 to 2030.

Seizures, characterized by abnormal movements or behavior resulting from unusual electrical activity in the brain, are hallmark symptoms of epilepsy, a chronic and non-communicable brain disease affecting individuals of all ages. These seizures manifest as brief episodes of involuntary movement. While several drugs are employed in the treatment of epileptic seizures, benzodiazepines are the most commonly utilized, renowned for their efficacy in seizure control.

Over recent years, advancements have led to the development of benzodiazepine drugs with improved effectiveness and reduced side effects, alongside innovative routes of administration. Additionally, other antiepileptic drugs such as phenytoin and fosphenytoin are also employed in the management of epileptic seizures.

๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐…: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=79717&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

๐Œ๐š๐ฃ๐จ๐ซ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ-

Bausch Health Companies, Inc.,GlaxoSmithKline plc.,UCB S.A.,Pfizer, Inc.,Apotex, Inc.,Alexza Pharmaceuticals, Inc.,Neurelis, Inc.,Veriton Pharma

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง-

๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ

Midazolam
Alprazolam
Diazepam
Lorazepam
Phenytoin
Fosphenytoin
Others

๐“๐ฒ๐ฉ๐ž

Repetitive Seizures
Status Epilepticus
Convulsive Status Epilepticus
Non-convulsive Status Epilepticus
Others

๐‘๐จ๐ฎ๐ญ๐ž ๐จ๐Ÿ ๐€๐๐ฆ๐ข๐ง๐ข๐ฌ๐ญ๐ซ๐š๐ญ๐ข๐จ๐ง

Oral/Buccal
Rectal
Nasal
Parenteral

๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

๐…๐จ๐ซ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐Ž๐Ÿ ๐“๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79717&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

In terms of region, the global epileptic seizures treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.

North America dominated the global epileptic seizures treatment market in 2019, and the trend is projected to continue during the forecast period

The current and future sizes of the epileptic seizures treatment market, in terms of value (US$ Mn), of regional markets and their major countries have been provided in the report for the period from 2018 to 2030, along with their CAGRs for the period from 2020 to 2030

๐Š๐ž๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐ฎ๐๐ฒ ๐๐จ๐ข๐ง๐ญ๐ฌ:

Epidemiology of epilepsy and its impact on healthcare systems.
Analysis of current treatment modalities and their efficacy.
Market dynamics including drivers, challenges, and trends shaping the market landscape.
Regulatory landscape and its implications on market entry and product development.
Competitive analysis highlighting key players, their strategies, and recent developments.

๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:

The Epileptic Seizures Treatment Market is poised for continued expansion, driven by ongoing research and development efforts, expanding treatment options, and a growing emphasis on patient-centric care. Key stakeholders are expected to collaborate to address unmet medical needs and improve treatment outcomes for epilepsy patients globally.

๐†๐ž๐ญ ๐“๐ก๐ข๐ฌ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ, ๐ˆ๐ง๐ฌ๐ญ๐š๐ง๐ญ๐ฅ๐ฒ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=79717<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐Œ๐จ๐ซ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐“๐Œ๐‘:

๐’๐ข๐ฅ๐ข๐œ๐จ๐ง ๐‚๐š๐ซ๐›๐ข๐๐ž ๐Œ๐Ž๐’๐…๐„๐“๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2023/06/13/2687582/0/en/Global-Silicon-Carbide-MOSFETs-Market-is-Expected-to-Accelerate-at-a-Whopping-29-8-CAGR-Reaching-US-13-5-Billion-by-2031-Transparency-Market-Research.html

๐ƒ๐ž๐ง๐ญ๐š๐ฅ ๐Œ๐ž๐ฆ๐›๐ซ๐š๐ง๐ž & ๐๐จ๐ง๐ž ๐†๐ซ๐š๐Ÿ๐ญ ๐’๐ฎ๐›๐ฌ๐ญ๐ข๐ญ๐ฎ๐ญ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2023/06/13/2687549/0/en/Dental-Membrane-Bone-Graft-Substitutes-Market-to-Witness-Promising-Growth-with-7-7-CAGR-in-the-Forecast-Period-2023-2031-Reports-TMR-Study.html

๐€๐›๐จ๐ฎ๐ญ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epileptic Seizures Treatment Market Expected to Reach US$ 1.8 Billion by 2030, Growing at a CAGR of 4%: TMR Study here

News-ID: 3390872 • Views: โ€ฆ

More Releases from Transparency Market Research

Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive AI Adoption and Next-Generation Edge Computing Innovations | TMR
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A โ€ฆ
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034. Examine key highlights andโ€ฆ
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological Disease Burden Accelerates | TMR
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological โ€ฆ
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-hasโ€ฆ
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Innovations in Gene Editing, Stem Cell Therapy, and AI-Based Neuromedicine | TMR
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn โ€ฆ
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue. Examine key highlights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322 With breakthroughsโ€ฆ
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Advances in Brain Mapping, AI, and Portable Neuroimaging | TMR
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv โ€ฆ
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation. Examineโ€ฆ

All 5 Releases


More Releases for Epileptic

Developmental and Epileptic Encephalopathies (DEE) - Patient Pool Analysis & Mar โ€ฆ
What are DEEs? Developmental and epileptic encephalopathies (DEEs) are a group of rare, severe, early-onset epilepsies in which epileptic activity itself contributes to progressive cognitive, motor and behavioural impairment. They include syndromes such as infantile epileptic spasms (West syndrome), Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), epilepsy with myoclonic-atonic seizures (EMAS/Doose), CDKL5 deficiency and many single-gene epilepsies. Children often present in the first months or years of life with multiple seizure types, resistantโ€ฆ
Prominent Epileptic Seizures Treatment Market Trend for 2025: Development -Based โ€ฆ
What combination of drivers is leading to accelerated growth in the epileptic seizures treatment market? The growing prevalence of epilepsy is anticipated to drive the growth of the epileptic seizures treatment market. Epilepsy is characterized by recurrent seizures caused by abnormal brain activity, leading to symptoms like convulsions or loss of consciousness. The rise in epilepsy cases is attributed to factors such as increased survival rates for brain injuries and strokes,โ€ฆ
Epileptic Seizures Treatment Market Analysis, Trends, Growth, Research And Forec โ€ฆ
The Business Research Company recently released a comprehensive report on the Global Epileptic Seizures Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusiveโ€ฆ
Poland Epileptic Seizures Treatment Market Foreseen to Grow Exponentially 2030
Epileptic Seizures Treatment Market: Introduction According to the report, the globalย epileptic seizures treatment marketย was valued at US$ย 1.2ย Bn in 2019 and is projected to expand at a CAGR of ~4% from 2020 to 2030. In epilepsy, the brain activity becomes abnormal, resulting in recurrent seizures that are short episodes of involuntary movement, which may involve a part of the body or the entire body. These seizures in some cases cause loss ofโ€ฆ
Epileptic Seizures Treatment Market: Lucrative Opportunities
Epileptic Seizures Treatment Market: Introduction According to the report, the globalย epileptic seizures treatment marketย was valued at US$ย 1.2ย Bn in 2019 and is projected to expand at a CAGR of ~4% from 2020 to 2030. In epilepsy, the brain activity becomes abnormal, resulting in recurrent seizures that are short episodes of involuntary movement, which may involve a part of the body or the entire body. These seizures in some cases cause loss ofโ€ฆ
Epileptic Seizure Monitoring System Market Projected to Register CAGR to 2027
The epileptic seizure monitor system is a seizure detection system that can be used in long-term and home situations for early intervention and prevention of seizure-related side effects, including SUDEP. The epileptic seizure monitoring system market is segmented by company, region (country), type, and application. Players, stakeholders, and other entrants of the global Seizure Monitoring System market can use the report as a powerful resource to gain an edge. (Get 15% Discountโ€ฆ